134
Views
7
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

The Resazurin Microplate Method for Rapid Detection of Vancomycin Resistance in Enterococci

Pages 361-366 | Published online: 18 Jul 2013

References

  • Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH (ed.) Manual of Clinical Microbiology, 8th ed., American Society for Microbiology, Washington, D.C., 2003: 210, 422-424, 1180–1181.
  • Harbarth S, Cosgrove S, Carmeli Y. Effects of antibi-otics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002; 46: 1619–28.
  • Diekema DJ, Dodgson KJ, Sigurdardottir B, Pfaller MA. Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need. J Clin Microbiol 2004 ; 42: 2879–83.
  • Manson JM, Keis S, Smith JMB, Cook GM. A clonal lin-eage of vanA-type Enterococcus faecalis predominates in vancomycin-resistant enterococci isolated in New Zealand. Antimicrob Agents Chemother 2003; 47: 204–10.
  • DeLise S, Perl TM. A road map on how to prevent the emergence and transmission of antimicrobial resistance. Chest 2003; 123: 504S-18S.
  • Hayden MK. Insight into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin Infect Dis 2000; 31: 1058–65.
  • McDonald LC, Garza LR, Jarvis WR. Proficiency of clin-ical laboratories in and near Monterrey, Mexico, to detect van-comycin-resistant enterococci. Emerg Infect Dis 1999; 5: 143–46.
  • National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically-fifth edition. Approved standard. NCCLS document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa, 2002.
  • Andrews JM. Determination of minimum inhibitory con-centrations. J Antimicrob Chemother 2001; 48 (Suppl. 1): 5-16.
  • Nagasawa Z, Manome I, Nagayama A. A rapid antimi-crobial susceptibility test based on chemiluminescence assay and its application to screening of genotypes in vancomycin-resistant enterococci. J Infect Chemother 2004; 10: 220–26.
  • Banfi E, Scialino G, Monti-Bragadin C. Development of a microdilution method to evaluation Mycobacterium tubercu-losis drug susceptibility. J Antimicrob Chemother 2003; 52: 796–800.
  • Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a Utility 2,3-bis(2-methoxy-4-nitro-5-sul-fophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of test-ing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 1998; 36: 1450-52.
  • Hawser SP, Jessup C, Vitullo J, Ghannoum MA. Utility 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)car-bonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal suscep-tibility of Aspergillus fumigatus to the lipopeptide class of compounds. J Clin Microbiol 2001; 39: 2738–41.
  • Lemus D, Martin A, Montoro E, Portaels F, Palomino JC. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2004; 54: 130–33.
  • Martin A, Camacho M, Portaels F, Palomino JC. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother 2003; 47: 3616–19.
  • Meletiadis J, Mouton JW, Meis JFGM, Bouman BA, Donnelly JP, Verweij PE, Network E. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 2001; 39: 3402–08.
  • Pfaller MA, Barry AL. Evaluation of a novel colorimet-ric broth microdilution method for antifungal susceptibility test-ing of yeast isolates. J Clin Microbiol 1994; 32: 1992–96.
  • Syre H, Phyu S, Sandven P, Bjorvatn B, Grewal HMS. Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liq-uid cultures. J Clin Microbiol 2003; 41: 5173–77.
  • Tunney MM, Ramage G, Field TT, Moriarty TF, Storey DG. Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2004; 48: 1879–81.
  • Magnani E, Bettini E. Resazurin detection of energy metabolism changes in serum starved PC12 cells and of neu-roprotective agent effect. Brain Res Protoc 2000; 5: 266–72.
  • Class II Special Controls Guidance Document. Antimicrobial susceptibility test (AST) systems; guidance for industry and FDA, http://www.fda.gov/cdrh./ode/631.pdf, 2003.
  • Andrews JM for the BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 3). J Antimicrob Chemother 2004; 53: 713-28.
  • Patel R. Clinical impact of vancomycin-resistant entero-cocci. J Antimicrob Chemother 2003; 51 (Suppl.53): iii13-iii21.
  • Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13: 686–707.
  • Endtz HP, Van Den Braak N, Van Belkum A, Goessens WH, Kreft D, Stroebel AB, Verbrugh HA. Comparison of eight methods to detect vancomycin resistance in enterococci. J Clin Microbiol 1998; 36: 592–94.
  • Tenover FC, Swenson JM, O'hara CM, Stocker SA. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococ-ci. J Clin Microbiol 1995; 33: 1524–27.
  • Gattringer R, Niks M, Ostertag R, Schwarz K, Medvedovic H, Graninger W, Georgopoulos A. Evaluation of MIDITECH automated colorimetric MIC reading for antimicro-bial susceptibility testing. J Antimicrob Chemother 2002; 49: 651–59.
  • Baker CN, Tenover FC. Evaluation of alamar colori-metric broth microdilution susceptibility testing methods for staphylococci and enterococci. J Clin Microbiol 1996; 34: 2654–59.
  • Zabransky RJ, Dinuzzo AR, Woods GL. Detection of vancomycin resistance in enterococci by the alamar MIC sys-tem. J Clin Microbiol 1995; 33: 791–93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.